These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 28774478)
1. Putting Glioblastoma in Its Place: IRF3 Inhibits Invasion. Pattwell SS; Holland EC Trends Mol Med; 2017 Sep; 23(9):773-776. PubMed ID: 28774478 [TBL] [Abstract][Full Text] [Related]
2. Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness. Pencheva N; de Gooijer MC; Vis DJ; Wessels LFA; Würdinger T; van Tellingen O; Bernards R Cell Rep; 2017 Jul; 20(1):48-60. PubMed ID: 28683323 [TBL] [Abstract][Full Text] [Related]
3. Dissecting Glioma Invasiveness in a 3D-Organotypic Model. Codega P; Mellinghoff IK Trends Mol Med; 2017 Sep; 23(9):776-777. PubMed ID: 28781061 [TBL] [Abstract][Full Text] [Related]
4. An Experimenter's Guide to Glioblastoma Invasion Pathways. de Gooijer MC; Guillén Navarro M; Bernards R; Wurdinger T; van Tellingen O Trends Mol Med; 2018 Sep; 24(9):763-780. PubMed ID: 30072121 [TBL] [Abstract][Full Text] [Related]
5. Differences in Extracellular Matrix Composition and its Role in Invasion in Primary and Secondary Intracerebral Malignancies. Virga J; Szemcsák CD; Reményi-Puskár J; Tóth J; Hortobágyi T; Csősz É; Zahuczky G; Szivos L; Bognár L; Klekner A Anticancer Res; 2017 Aug; 37(8):4119-4126. PubMed ID: 28739696 [TBL] [Abstract][Full Text] [Related]
6. The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors. Yamamoto M; Ueno Y; Hayashi S; Fukushima T Anticancer Res; 2002; 22(6C):4265-8. PubMed ID: 12553067 [TBL] [Abstract][Full Text] [Related]
7. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041 [TBL] [Abstract][Full Text] [Related]
8. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion. Liu B; Dong H; Lin X; Yang X; Yue X; Yang J; Li Y; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Mao S; Chen Q; Chang J Oncotarget; 2016 Dec; 7(50):82411-82423. PubMed ID: 27705942 [TBL] [Abstract][Full Text] [Related]
10. Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme. Tilak M; Holborn J; New LA; Lalonde J; Jones N Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673213 [TBL] [Abstract][Full Text] [Related]
11. Yes and PI3K bind CD95 to signal invasion of glioblastoma. Kleber S; Sancho-Martinez I; Wiestler B; Beisel A; Gieffers C; Hill O; Thiemann M; Mueller W; Sykora J; Kuhn A; Schreglmann N; Letellier E; Zuliani C; Klussmann S; Teodorczyk M; Gröne HJ; Ganten TM; Sültmann H; Tüttenberg J; von Deimling A; Regnier-Vigouroux A; Herold-Mende C; Martin-Villalba A Cancer Cell; 2008 Mar; 13(3):235-48. PubMed ID: 18328427 [TBL] [Abstract][Full Text] [Related]
12. Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes. Ladha J; Donakonda S; Agrawal S; Thota B; Srividya MR; Sridevi S; Arivazhagan A; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Kondaiah P; Somasundaram K; Santosh V; Rao SM Cancer Res; 2010 Aug; 70(16):6437-47. PubMed ID: 20663907 [TBL] [Abstract][Full Text] [Related]
13. Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness. Schulze M; Fedorchenko O; Zink TG; Knobbe-Thomsen CB; Kraus S; Schwinn S; Beilhack A; Reifenberger G; Monoranu CM; Sirén AL; Jeanclos E; Gohla A Oncogene; 2016 Jun; 35(24):3163-77. PubMed ID: 26549022 [TBL] [Abstract][Full Text] [Related]
15. Clonal composition of glioblastoma multiforme. Berkman RA; Clark WC; Saxena A; Robertson JT; Oldfield EH; Ali IU J Neurosurg; 1992 Sep; 77(3):432-7. PubMed ID: 1324297 [TBL] [Abstract][Full Text] [Related]
16. Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks. Chakraborty S; Li L; Puliyappadamba VT; Guo G; Hatanpaa KJ; Mickey B; Souza RF; Vo P; Herz J; Chen MR; Boothman DA; Pandita TK; Wang DH; Sen GC; Habib AA Nat Commun; 2014 Dec; 5():5811. PubMed ID: 25503978 [TBL] [Abstract][Full Text] [Related]
17. PREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion. Gont A; Daneshmand M; Woulfe J; Lavictoire SJ; Lorimer IA Oncotarget; 2017 Jan; 8(5):8559-8573. PubMed ID: 28051998 [TBL] [Abstract][Full Text] [Related]
18. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation. Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017 [TBL] [Abstract][Full Text] [Related]
19. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534 [TBL] [Abstract][Full Text] [Related]
20. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme. Musumeci G; Magro G; Cardile V; Coco M; Marzagalli R; Castrogiovanni P; Imbesi R; Graziano AC; Barone F; Di Rosa M; Castorina S; Castorina A Cell Tissue Res; 2015 Oct; 362(1):45-60. PubMed ID: 25948484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]